
Environmental Cleaning and Disinfection: Break the Chain of Infection
Overview Over the course of the last three years, infection prevention and healthcare technology management leaders needed to rapidly adjust to prevent the spread of SARS-CoV-2. Now, with the c...

Navigating Staffing Shortages: How PSOs as Learning Systems can Reduce Risks
Overview Staffing shortages pose a significant challenge to healthcare organizations. While the strain of caring for COVID-19 patients continues to decrease as the number of case drop, hospital...

Implementation science aims to discover and apply strategies that accelerate successful integration of interventions into routine practice. This initiative will provide background information on th...

The term “polypharmacy” most commonly refers to a situation where a patient is being treated with many, five or more, medications. Patients of all ages may potentially receive many medications. The...

Errors Associated with Paxlovid
Paxlovid was authorized under the emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in December 2021 and is used for mild-to-moderate coronavirus 2019 (COVID-19) in ad...

The Pursuit of Prevention – Confronting Drug Diversion
Drug diversion is a serious problem that affects patients’ and health professionals’ safety. Patients may suffer from suboptimal therapy if their medications were diverted, receive substandard care...

Home-use Device Recalls: What You Need to Know to Mitigate Risk and Protect Patients
Overview When a medical device is subject to a recall, manufacturers are responsible for informing their affected customers—healthcare providers, retailers, and distributors—to prevent use of t...

Introducing ISMP’s New Targeted Medication Safety Best Practices for Community Pharmacy: 2023-2024
Join ISMP for a complimentary webinar as we seek to inspire and mobilize practitioners from around the US in the national adoption of specific consensus-based safe practices selected to reduce or e...

Errors Associated with COVID-19 Vaccines
In December 2020, the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to both the Pfizer-BioNTech and Moderna coronavirus disease 2019 (COVID-19) vaccines. Since the...
